Chemical Component Summary

NameLSZ102
Synonyms(2E)-3-[4-({2-[2-(1,1-difluoroethyl)-4-fluorophenyl]-6-hydroxy-1-benzothiophen-3-yl}oxy)phenyl]prop-2-enoic acid
Identifiers(~{E})-3-[4-[[2-[2-[1,1-bis(fluoranyl)ethyl]-4-fluoranyl-phenyl]-6-oxidanyl-1-benzothiophen-3-yl]oxy]phenyl]prop-2-enoic acid
FormulaC25 H17 F3 O4 S
Molecular Weight470.46
TypeNON-POLYMER
Isomeric SMILESCC(c1cc(ccc1c2c(c3ccc(cc3s2)O)Oc4ccc(cc4)/C=C/C(=O)O)F)(F)F
InChIInChI=1S/C25H17F3O4S/c1-25(27,28)20-12-15(26)5-9-18(20)24-23(19-10-6-16(29)13-21(19)33-24)32-17-7-2-14(3-8-17)4-11-22(30)31/h2-13,29H,1H3,(H,30,31)/b11-4+
InChIKeySJXNPGGVGZXKKI-NYYWCZLTSA-N

Chemical Details

Formal Charge0
Atom Count50
Chiral Atom Count0
Bond Count53
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB15362 
NameLSZ-102
Groups investigational
DescriptionLSZ-102 is under investigation in clinical trial NCT02734615 (Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers).
SynonymsLSZ-102
CategoriesSulfur Compounds
CAS number2135600-76-7

Related Resource References

Resource NameReference
Pharos CHEMBL4076124
PubChem 118574930
ChEMBL CHEMBL4076124